mAbsolve has now had patents for the STR silencing mutations granted in the United States (US12037380B2), Canada (CA3179582), United Kingdom (GB2595299B), Australia (AU2021277578B2) and Japan (JP7434609B2). We continue to push forward with our applications in other territories and expect these to be awarded in due course.
